2020
DOI: 10.1016/j.sajb.2020.02.023
|View full text |Cite
|
Sign up to set email alerts
|

In vitro cytotoxic activity of certain succulent plants against human colon, breast and liver cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 29 publications
0
5
0
1
Order By: Relevance
“…does not possess antitumor activity against A-549 [42] and with Abdul-Hafeez et alwho proved the low cytotoxic activity of S. trifasciata Prain. against colon, breast and hepatic cell lines [9]. On the other hand, S. suffruticosa N.E.Br.…”
Section: Discussionmentioning
confidence: 99%
“…does not possess antitumor activity against A-549 [42] and with Abdul-Hafeez et alwho proved the low cytotoxic activity of S. trifasciata Prain. against colon, breast and hepatic cell lines [9]. On the other hand, S. suffruticosa N.E.Br.…”
Section: Discussionmentioning
confidence: 99%
“…Dracaena (Sansevieria) trifasciata is an important ethnomedicinal plant that is readily available at a very economical price in Pakistan. Literature associates anti-diabetic, anti-tumor, anti-oxidant, and anti-microbial activities with species of this genus thus corroborating its pharmacological potential [ 20 ]. However, elucidation of the functional role and cellular mechanisms by which compounds from Dracaena trifasciata may modulate the metabolic reprogramming in RA remains untapped in the literature.…”
Section: Introductionmentioning
confidence: 87%
“…Bu sebeple yapılan çalışmalar yoğunlukla kanser tedavisinde kullanılabilecek nitelikte olan ilaç etken maddeleri üzerinde yoğunlaşmıştır. 4,5 Tıbbi bitkiler; tedavi amaçlı kullanımı ön planda olan ilaç formülasyonlarına etken madde sağlamak için sınırsız imkanlar sunan, önemli ana kaynaklar olarak kabul edilmektedir ve klinik modern ilaç etken maddelerin yaklaşık %50'si bitkisel kökenlidir. 4 Özellikle son yıllarda kanser hastalıklarında tedavi amaçlı kullanılan bitkiler, sahip oldukları sekonder metabolitler sebebiyle oldukça detaylı bir şekilde çalışılmaya başlanmıştır.…”
Section: 2unclassified